Synthesis and Biological Evaluation of 1,3,4-Oxadiazole Derivatives as Acetylcholinesterase Inhibitors

A series of 1,3,4-oxadiazole derivatives were designed, synthesized, and evaluated as acetylcholin­esterase inhibitors. Their structure was confirmed by IR, NMR, and high-resolution mass spectra. The syn­thesized compounds showed significant acetylcholinesterase inhibitory activity with an IC 50 val...

Full description

Saved in:
Bibliographic Details
Published in:Russian journal of organic chemistry 2022-10, Vol.58 (10), p.1520-1526
Main Authors: Yang, Shun, Zou, Jing-Pei, Li, Xiang-Rong, Li, Rui, Qian, Jing-Jing, Wu, Wen-Long, Su, Jia-Bin, Chen, Ke-Qi, Qin, Tian, Liu, Shan-Ming, Liu, Wei-Wei, Shi, Da-Hua
Format: Article
Language:English
Subjects:
Amino acids
Chemistry
Chemistry and Materials Science
Inhibitors
Mass spectra
Molecular docking
NMR
Nuclear magnetic resonance
Organic Chemistry
Oxadiazoles
Synthesis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A series of 1,3,4-oxadiazole derivatives were designed, synthesized, and evaluated as acetylcholin­esterase inhibitors. Their structure was confirmed by IR, NMR, and high-resolution mass spectra. The syn­thesized compounds showed significant acetylcholinesterase inhibitory activity with an IC 50 value of 0.07 μM for the most potent compound. Molecular docking study of the most active compound indicated that it interacted with the crucial amino acids present at the catalytic active site and peripheral anionic site of acetylcholinesterase. The results suggested that the obtained 1,3,4-oxadiazole derivatives may be the potential drug candidates for the treatment of Alzheimer’s disease as AChE inhibitors.
ISSN:1070-4280
1608-3393
DOI:10.1134/S1070428022100207